Audio narrative by Dr. Matthew Leoni, Senior Manager of Clinical Research at Immunomedics, and is accompanied by PET Scans of the two patients, which show both a significant reduction in the size of their metastasized tumors and an impairment of the tumors metabolic activity.
Link to this comment:
All Comments (0)